Author: Löffler, Christian; Mahrhold, Juliane; Fogarassy, Peter; Beyer, Martin; Hellmich, Bernhard
Title: Two immunocompromised patients with diffuse alveolar hemorrhage as a complication of severe COVID-19 Cord-id: 18l9juk8 Document date: 2020_7_2
ID: 18l9juk8
Snippet: Abstract Diffuse alveolar hemorrhage (DAH) is a severe and potentially life-threatening disease manifestation. Besides autoimmune diseases such as anti-neutrophil cytoplasmatic antibody (ANCA) associated vasculitis and anti-glomerular basement membrane (anti-GBM) syndrome pulmonary viral infections are also known to be culprits of DAH. The coronavirus disease 2019 (COVID-19) pandemic confronts healthcare providers all around the world with an unprecedented number of viral lung infections with a
Document: Abstract Diffuse alveolar hemorrhage (DAH) is a severe and potentially life-threatening disease manifestation. Besides autoimmune diseases such as anti-neutrophil cytoplasmatic antibody (ANCA) associated vasculitis and anti-glomerular basement membrane (anti-GBM) syndrome pulmonary viral infections are also known to be culprits of DAH. The coronavirus disease 2019 (COVID-19) pandemic confronts healthcare providers all around the world with an unprecedented number of viral lung infections with a great variance in symptoms and severity. Hemoptysis being the key symptome of DAH has so far been reported to be rare. We present two cases of immunocompromised patients with rapidly developing hypoxemic respiratory failure and evidence of DAH in the context of SARS-CoV-2 infection.
Search related documents:
Co phrase search for related documents- action mode and lung infection: 1, 2
- admission prior and low prevalence: 1, 2
- admission prior and lung infection: 1
- low prevalence and lung infection: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date